Precision Medicine is the practice of making tailored healthcare and clinical decisions to patients based on their intrinsic biological information as well as clinical symptoms and signs. In recent years, the genetic research and precise diagnosis and treatment of epilepsy have gradually become the fastest growing research direction in the field of epilepsy. The application of precision medicine in epilepsy aims to play an important role in the diagnosis and treatment of epilepsy according to the associated genes and specific molecular changes, so as to provide individual treatment strategies for patients with epilepsy.
Guest Editor
Prof. Weiping Liao
Professor of department of neurology in Guangzhou Medical University, director of Institute of Neuroscience of Guangzhou Medical University, and director of Key Laboratory of Neurogenetics and Ion Channel Disease of the Ministry of Education.
He is currently the chairman of the Precision Medicine and Adverse Drug Reaction Monitoring Committee of China Anti-Epilepsy Association, the Government Special Subsidy Expert of the State Council, the Epilepsy Ambassador of the International League Against Epilepsy (ILAE), the Chairman of the ILAE Education Working Committee, and the Associated Editor-in-Chief of Seizure.
This series was published in Acta Epileptologica.
Here are the articles in the series: